XylT-I Activators refers to a group of chemical compounds that have the unique ability to stimulate the activity of the enzyme Xylosyltransferase I (XylT-I). XylT-I is an essential enzyme involved in glycosylation, a crucial post-translational modification process in which sugar molecules are added to proteins, particularly within the context of proteoglycans. Proteoglycans play vital roles in various biological processes, including the formation of connective tissues and extracellular matrix, cell adhesion, and tissue development. XylT-I serves as the initiator of this glycosylation process by transferring xylose sugar molecules to the core protein structure of proteoglycans. Thus, XylT-I activators are instrumental in modulating the activity of this enzyme and, in turn, influencing the structure and function of proteoglycans.
The mechanisms by which XylT-I activators function can vary, but their commonality lies in their ability to enhance the catalytic activity of XylT-I. They may directly interact with XylT-I to enhance its enzymatic activity or indirectly modulate the cellular processes and pathways that regulate XylT-I. These compounds are valuable tools for researchers in the field of glycosylation and proteoglycan biology, enabling a deeper understanding of the intricate mechanisms underlying these processes. By facilitating the activation of XylT-I, researchers can explore the implications of altered proteoglycan structures and their impact on various cellular functions, which can, in turn, have broader implications in the fields of cell biology and tissue engineering.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
A compound that activates the TGF-beta receptor, indirectly stimulating XylT-I through the TGF-beta signaling pathway. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A protein kinase inhibitor that indirectly activates XylT-I by modulating various protein kinases involved in glycosylation processes. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
A disruptor of the Golgi apparatus, indirectly promoting glycosylation, including XylT-I's role in this process. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
An enhancer of alpha-glucosidases, indirectly activating glycosylation, including XylT-I-mediated xylose transfer. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
An inhibitor of N-glycosylation, indirectly stimulating glycosylation processes, including XylT-I-mediated xylose transfer. | ||||||
4-Phenylbutyric acid | 1821-12-1 | sc-232961 sc-232961A sc-232961B | 25 g 100 g 500 g | $53.00 $136.00 $418.00 | 10 | |
A chemical chaperone that indirectly promotes proper protein folding, potentially activating XylT-I activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
An inducer of endoplasmic reticulum (ER) stress, which may indirectly activate XylT-I by enhancing glycosylation processes. | ||||||
Sodium chlorate | 7775-09-9 | sc-212938 | 100 g | $59.00 | 1 | |
An inhibitor of sulfation, important in proteoglycan synthesis, indirectly stimulating glycosylation, including XylT-I's role. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Known to modulate proteoglycan synthesis and may indirectly activate XylT-I activity by enhancing glycosylation. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
A chemical impacting intracellular transport and Golgi apparatus function, potentially indirectly stimulating XylT-I's role in glycosylation. | ||||||